Russia plans to register the world’s first vaccine against SARS CoV-2 infection on August 12, according to agency reports quoting Deputy Health Minister Oleg Gridnev.
The vaccine has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry. The vaccine, which uses inanimate particles created on the basis of adenovirus, raises no concerns that the vaccine could potentially cause harm to a person’s health, said Alexander Gintsburg, director of the Gamaleya National Research Centre, to Sputnik News.
“The particles and objects that can reproduce their own kind are the ones that are considered alive. The particles in question cannot multiply,” Gintsburg was quoted in the report.
Russia may offer this vaccine, which was tried by the GNRC team, including Dr Gintsburg, first to the “risk groups” such as medical workers this month and the mass vaccination may begin as early as October.